ALKS
Price:
$44.99
Market Cap:
$7.50B
Alkermes plc is an Irish-headquartered biopharmaceutical firm, established in 1987, focused on the discovery, development, and commercialization of innovative pharmaceutical treatments. These efforts are directed at fulfilling critical unmet medical needs for patients across a range of therapeutic areas, both domestically and internationally. Its current portfolio of marketed products features ARISTADA for schizophrenia; VIVITROL, targeting alcohol dependence and preventing opioid dependence; and several medications for schizophrenia and bipolar I disorder, including RISPERDAL CONSTA, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, and TREVICTA. Furthermore, VUMERITY is available for managing relap...[Read more]
Industry
Biotechnology
IPO Date
1991-07-16
Stock Exchange
NASDAQ
Ticker
ALKS
According to Alkermes plc’s latest financial reports and current stock price. The company's current Current Ratio is 2.27. This represents a change of -28.73% compared to the average of 3.18 of the last 4 quarters.
The mean historical Current Ratio of Alkermes plc over the last ten years is 2.95. The current 2.27 Current Ratio has changed 7.59% with respect to the historical average. Over the past ten years (40 quarters), ALKS's Current Ratio was at its highest in in the December 2016 quarter at 4.30. The Current Ratio was at its lowest in in the March 2022 quarter at 2.19.
Average
2.95
Median
2.87
Minimum
2.25
Maximum
4.30
Discovering the peaks and valleys of Alkermes plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 25.75%
Maximum Annual Current Ratio = 4.30
Minimum Annual Increase = -22.92%
Minimum Annual Current Ratio = 2.25
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 3.55 | 16.68% |
| 2024 | 3.04 | 6.55% |
| 2023 | 2.86 | 25.75% |
| 2022 | 2.27 | 0.76% |
| 2021 | 2.25 | -11.09% |
| 2020 | 2.53 | 3.07% |
| 2019 | 2.46 | -15.01% |
| 2018 | 2.89 | -12.79% |
| 2017 | 3.32 | -22.92% |
| 2016 | 4.30 | -0.21% |
The current Current Ratio of Alkermes plc (ALKS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.15
5-year avg
2.79
10-year avg
2.95
Alkermes plc’s Current Ratio is less than PTC Therapeutics, Inc. (2.44), less than Arcellx, Inc. (4.44), less than Protagonist Therapeutics, Inc. (17.76), less than ACADIA Pharmaceuticals Inc. (3.59), less than TG Therapeutics, Inc. (5.81), less than Arrowhead Pharmaceuticals, Inc. (6.23), less than Vaxcyte, Inc. (7.49), less than CRISPR Therapeutics AG (17.96), less than Akero Therapeutics, Inc. (15.83), less than Kymera Therapeutics, Inc. (10.81),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.44 | $6.55B | |
| 4.44 | $6.73B | |
| 17.76 | $7.26B | |
| 3.59 | $3.70B | |
| 5.81 | $8.15B | |
| 6.23 | $11.52B | |
| 7.49 | $7.43B | |
| 17.96 | $5.22B | |
| 15.83 | $4.50B | |
| 10.81 | $7.44B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alkermes plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alkermes plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Alkermes plc's Current Ratio?
How is the Current Ratio calculated for Alkermes plc (ALKS)?
What is the highest Current Ratio for Alkermes plc (ALKS)?
What is the 3-year average Current Ratio for Alkermes plc (ALKS)?
What is the 5-year average Current Ratio for Alkermes plc (ALKS)?
How does the current Current Ratio for Alkermes plc (ALKS) compare to its historical average?